カイロで最高の腫瘍科医師 - トップ9名の医師

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.

Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).

Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.

Dr. Amr Mahmoud Al Demery is a consultant thoracic surgical oncologist with 12 years of experience. He holds an M.B.B.Ch from Kasr El-Aini, Cairo University (2007). He earned a Master’s in Surgical Oncology in 2014 and a Doctorate in Surgical Oncology in 2019 from the National Cancer Institute, Cairo University. He is a Member of the Royal College of Surgeons of England (MRCS, 2014). He speaks English and Arabic.

His practice includes the assessment, diagnosis, and surgical treatment of thoracic cancers. He performs bronchoscopy, thoracoscopy, and mediastinoscopy. He carries out lung resections, including wedge resection, lobectomy, bilobectomy, and pneumonectomy. He also performs esophageal resection with reconstruction and pleural decortication. His work includes thymectomy and mediastinal lymph node dissection. He performs chest wall and diaphragmatic tumor resection with reconstruction.

He served as Resident, Assistant Lecturer, and Lecturer of Surgical Oncology at the National Cancer Institute, Cairo University. He is a consultant in thoracic surgical oncology at Dar El-Salam, Tanta, Damanhour, and Shefaa Al Orman Cancer Centers. He is a member of the Egyptian Society of Surgical Oncology. He is a cofounder and member of the Egyptian Society of Respiratory Neoplasms.

Dr. Tamer Mostafa Manie is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University. He is also a Consultant Breast and Oncoplastic Surgeon at Shefa Al Orman. He performs breast cancer surgery and reconstruction. His work includes CBS, mastectomy, and lumpectomy. He performs sentinel and axillary staging. He offers implant and expander reconstruction and flap options (LD, TDAP, LICAP, AICAP, TRAM, SEAP). He also performs supermicrosurgery for lymphedema. He was Breast Cancer MDT Chairman at Madinet Nasr Oncology Center from 2021 to 2023.

Qualifications: MBBCh (2003), Master’s in Surgical Oncology (2009), Doctorate in Surgical Oncology (2014). International training: Heart of England NHS Trust (2013), European Institute of Oncology, Milan (2013–2014), Nottingham Breast Institute (2023). Memberships: EGSSO and the European Society of Surgical Oncology.

Dr. Tarek M. Hashem is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University (since 2020). He is also a Consultant in Breast and Oncoplastic Surgery at Shefa Al Orman Comprehensive Cancer Center in Luxor (2018–present).

Focus: breast cancer management and oncoplastic surgery. Procedures include breast-conserving surgery, mastectomy, and lumpectomy. Axillary staging includes sentinel lymph node biopsy and axillary dissection. He performs reduction mammoplasty and mastopexy. Reconstruction options include implants, expanders, and flaps (LD, TDAP, LICAP, AICAP, TRAM, SEAP), as well as nipple reconstruction and lipofilling. He also performs supermicrosurgery for lymphedema.

Credentials: MBBCh (Kasr El-Aini, Cairo University). MRCS (England, 2008). Master’s in General Surgery (Kasr El-Aini, Cairo University, 2009). International Breast Surgery Fellowship per EUSOMA (Marienhospital Düsseldorf, 2011). Fellowship in Breast Surgery (Heidelberg University Hospital, 2013). Doctoral degree in Surgical Oncology (2015).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.